Study confirms that certain conditions are direct result of acne treatment;call on whether patient should continue drug should involve ophthalmologist
Unlocking Optimal AD Treatment: From Triggers to JAK Inhibitors
The Cutaneous Connection: A Reminder of Patient Impact
Prebiotic Skin Care’s Effectiveness in AD for SOC Patients
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Derm-Biome and TransBIOtech Awarded $450,000 ARD Grant Funding for Inflammatory Disease and Skin Aging Research
Insights Into Clear Health’s Low-Dose Microdose Accutane Protocol For Mild Acne